Tesamorelin: Research Peptide for Growth Hormone and Visceral Fat Studies

Tesamorelin is a synthetic peptide analog of GHRH (Growth Hormone–Releasing Hormone), intended strictly for scientific and research purposes. It is widely studied for its ability to significantly increase IGF-1 levels and support reduction of visceral fat in controlled experimental settings.

Key areas of research interest:

• Investigating the mechanisms of visceral fat reduction,

• Studying GH/IGF-1 pathway stimulation,

• Exploring metabolic and regenerative effects in model organisms.

Tesamorelin has a longer half-life (~2 hours) compared to traditional GHRP peptides and is typically administered via subcutaneous injection in laboratory protocols. Its effects are specific, stable, and well-documented in both clinical and preclinical studies.

Usage

This product is intended for scientific and laboratory research purposes only. It is not a drug, dietary supplement, or medication for human or veterinary use.

Tesamorelin Dosage:

Dosage and administration are determined by laboratory professionals based on the specific needs and objectives of their research.

Form

Lyophilized powder.

Reconstitution and Storage of Peptides

Store lyophilized peptides at -20 ºC. A suitable solvent for reconstitution is 0.9% sodium chloride (NaCl) physiological solution.

Once reconstituted, store peptide at 2–8 ºC and use within a recommended period according to laboratory protocols.